title: Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results.
abstract: We have set up a cohort of human immunodeficiency virus (HIV) positive and negative patients with tuberculosis in order to address the problems associated with HIV-related tuberculosis. We present here the results of sputum smear microscopy, culture, mycobacterial identification tests and drug susceptibility assays from specimens taken at presentation. In this selected population of largely pulmonary tuberculosis cases, HIV infection is not associated with significant differences in sputum smear positivity rate, culture positivity rate or initial drug resistance. No atypical mycobacteria were found. Direct sputum smear examination remains specific for the diagnosis of tuberculosis in Kenya in spite of the presence of HIV. HIV infection was not associated with an increase in the proportion of pulmonary cases still culture-positive at 6 months. However a significant increase in the proportion of cases still culture-positive at 6 months was seen in those with initially resistant strains and also in those treated with standard regimen (streptomycin, thiacetazone and isoniazid for 1 month followed by thiacetazone and isoniazid for 11 months, 1STH/11TH) rather than a short-course, rifampicin-containing regimen (rifampicin, pyrazinamide and isoniazid for 2 months, together with streptomycin for the first month and followed by 6 months of thiacetazone and isoniazid, SHRZ/6TH).
authors: Kenya Medical Research Institute, Nairobi.
authors: W
authors: W
authors: Githui
authors: P
authors: P
authors: Nunn
authors: E
authors: E
authors: Juma
authors: F
authors: F
authors: Karimi
authors: R
authors: R
authors: Brindle
authors: R
authors: R
authors: Kamunyi
authors: S
authors: S
authors: Gathua
authors: C
authors: C
authors: Gicheha
authors: J
authors: J
authors: Morris
authors: M
authors: M
authors: Omwega
mesh_terms: D015331:Cohort Studies; D004351:Drug Resistance; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007630:Kenya; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011446:Prospective Studies; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000382:microbiology